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INTRODUCTION
Skin diseases can profoundly impair general well-being and self-respect, posing a real threat of issues with mental health, leading to severe depression and 
even suicide.[1,2] Patients with eczema and psoriasis are 
susceptible to long-term comorbidities that have a further 
impact on quality of life (QoL).[3] Their relationship with 
the healthcare provider may last for years, and despite the 
longevity of these relationships, many of the personal, 
psychological, and economic strains experienced by the 
patients go undisclosed.[4] Patient’s feedback data from 
routine clinical practice are found to be useful in health care 
cost-effectiveness research and in improving the quality of 
the service.[5] However, the limited physician consultation 
time leaves patients with a finite opportunity to address 
their needs, comorbidities, and feedback on the service they 
received.[6]
Health information technology tools such as eHealth and 
patient portal systems (PPS) have been adopted by many 
health care organizations since the late 1990s to enable 
patient-provider communication.[7] We conducted a postal 
survey on patients with psoriasis and eczema using the study 
tool in the form of a questionnaire. The survey was followed 
ORIGINAL ARTICLE
Assessing Comorbidities, Quality of Life, and the 
Needs of Patients with Psoriasis and Eczema at 
Each Consultation; Can Their Needs be Assessed 
and Met Online?
Taha Aldeen1, Julie Taylor2, Elizabeth Bates2
1Department of Dermatology, Queen’s Hospital, Romford, Essex, United Kingdom, 2Department of  Psychology 
and psychological Therapies, Institute of Health, University of Cumbria, Cumbria, United Kingdom
ABSTRACT
Background: Research showed that patients with psoriasis and eczema often suffer from comorbidities and their needs are 
not always assessed or met. Objective: The objective of the study was to develop an assessment tool to address the needs, 
comorbidities, and feedback of patients with psoriasis and eczema and to obtain their view on using the tool. Methods: A 
mixed-method research included a quantitative (postal survey) and a qualitative (face-to-face interview) to capture patients’ 
opinions and feedback. Results: In the postal survey, the majority (95%) of the participants reported physical, metabolic, 
and psychological comorbidities. Almost 30% of them stated that they could not cope with their chronic skin disease and 
10.5% had depression and suicidal thoughts. Around 24% of them expressed the need for support at home and 14% asked 
for support at work. All the interviewed participants agreed that the regular use of the study tool can address their needs 
and enhance their competence to self-manage their illness. Conclusions: The new study tool disclosed heterogeneous 
information on patients’ needs, management barriers, and comorbidities. Regular use of the tool at each consultation was 
welcomed by all the interviewed participants as it can fill important gaps in their management and in service improvement.
Key words: Assessment tool, comorbidities, eczema, needs, portal system, psoriasis, quality of life, self-management, 
survey
Address for correspondence:  
Dr. Taha Aldeen, Department of Dermatology, Queen’s Hospital, Romford, Hornchurch - RM11 2BZ, Essex,  
United Kingdom.
© 2020 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license.
Aldeen, et al.: Assessing comorbidities and needs of psoriasis and eczema patients
2 Clinical Research in Dermatology • Vol 3 • Issue 1 •  2020
by interviewing patients who participated in the survey to 
understand their needs and to capture their opinions on using 
the study tool or its online version at each consultation to 
address their needs and comorbidities.
METHODS
Participants
This is a two-step mixed-method exploratory study. The first 
phase of the research included a postal survey assessing the 
needs, views, and comorbidities of patients with psoriasis 
and eczema using the study tool. The tool consisted of a 
questionnaire that contained a dermatology life quality index 
(DLQI) and 8 supplementary open-ended questions to enable 
patients to express their views, needs, coping mechanisms, 
and comorbidities and to elaborate on different aspects of 
their care. In December 2017, a pilot study was conducted 
on 23 patients with psoriasis and eczema in a dermatology 
department of one of the National Health Service (NHS) 
hospitals in England. In January 2018 and for 3 months, a 
postal survey was conducted on adult patients with similar 
skin diseases and managed by the same hospital. The study’s 
patient information sheet, study tool, and self-addressed 
envelope were posted to 482 consecutive eligible patients. 
The inclusion criteria were broad, with adult male and female 
patients with psoriasis or eczema aged 18 years or older and 
able to provide consent, read, and understand the English 
language. The patients who agreed to participate in this study 
were asked to fill out and post back the study tool to the same 
hospital.
The second phase of the study included an audio-recorded 
face-to-face semi-structured interview with 22 patients who 
had participated in the postal survey. Written informed consent 
was obtained from each participant before the interview. The 
interview was focused on understanding patients’ needs and 
to capture their view on using the study tool or any other 
alternative tool at each hospital consultation and preference 
of using PPS. Patients in this study had no access to a PPS. 
Their opinions were based on hypothetical PPS. They were 
interviewed in the same hospital where the pilot study was 
conducted. Verbatim transcript and a coding process were 
used. No funding was received for this study and no incentive 
was offered to the participants. The study printing materials 
and postage costs were covered by the sponsored hospital. 
Ethical-approval for the above studies was obtained locally 
and nationally. All the materials used in the research were 
processed, managed, and stored in line with the general data 
protection regulations of 2018.
Data analysis
The data obtained from the survey were transferred into a 
spreadsheet after comparing each participant’s response with 
his/her hospital notes and were analyzed by gender, age, 
comorbidities, topical treatment preference, patient feedback 
on the service received, patient coping mechanisms, patient 
needs, disease triggers, and by the DLQI score. The latter 
index contains 10 questions and is calculated by summing 
the score of each question resulting in a maximum of 30 and 
a minimum of 0. The higher the score, the lower the patients 
rating of their QoL.[5]
All interviews were transcribed and thematically coded after 
comparing the similarities between participants’ responses. 
Both studies were conducted and analyzed by one researcher 
and regularly reviewed by two academic supervisors.
RESULTS
Postal survey results
One hundred and fourteen patients (including all the 
volunteers in the pilot study) participated in the postal survey. 
Thirty participants (26.3%) had eczema, and 84 (73.7%) had 
psoriasis. The female/male ratio was 58/56. The age range was 
between 18 and 88 years and the average age was 51.2 years. 
Of the 391 patients who did not participate in the postal survey, 
101 (25.8%) had eczema and 290 (74.2%) had psoriasis. Their 
female/male ratio was 195/196 and they had a similar age 
range, but with an average age of 44.4 years [Table 1].
Comorbidities were present in 95% of participants, as 
follows: 45.6% had joint pain or arthritis, 22.8% had high 
blood pressure, 15.7% had high lipid profile, 14% had 
poor mobility, 12.2% had diabetes, and 11.4% were obese. 
Psychologically, 28.9% could not cope alone with their 
chronic skin disease, 16.6% were unable to deal with the 
stigma of their skin disease, 16.6% had insomnia, 15.7% were 
suffering from anxiety, 10.5% had depression and suicidal 
thoughts, and 8.7% have no family support [Figure 1].
Stress was the dominant disease triggering factor in 63.1% 
patients, and the cold weather was the second most common 
trigger in 45.6% patients [Table 2]. The coping mechanisms 
reported by participants to deal with their chronic skin 
disease were; watching TV or listening to music for 55.2% of 
participants, comfort eating for 24.5%, practicing hobbies for 
17.5%, practicing religion or praying for 16.6%, working late 
Figure 1: Participants’ comorbidities
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hours for 5.2%, using antidepressant medication for 5.2%, 
reading for 4.3%, socializing for 4.3%, and practicing sport 
for 3.5%. Other mechanisms were used by a smaller number 
of participants; talking to friends, making self-busy, trying to 
ignore it, sleeping, walking the dog, and using fidget spinner.
The DLQI score of participants ranged from 0 to 26 and 37% 
was scoring more than 10. Five of those who scored more than 
10 were receiving systemic therapy, including biologics. The 
average DLQI for male participants was 8.45 and for female 
participants was 8.1, while the average DLQI in eczema 
patients was 10.7 and in psoriasis patients was 8.29 [Table 1].
As for patients’ needs, 45.6% participants asked for more 
and longer appointments with their dermatologist, 26.3% 
asked for more and longer appointment with their GP, 
25.4% requested for more health information, 23.6% asked 
support at home, and 14% of them requested support at work 
[Figure 2]. Around 18% of participants rated the service they 
received from their GP as poor, and further 3.5% participants 
rated it as very poor, while 7.8% participants rated the service 
they received from their dermatologist as poor and further 
2.6% participants rated it as very poor.
The majority of participants (93.8%) were using topical 
therapy for their skin disease and 38.5% felt that such 
a therapy was inconvenient to apply as frequently as is 
recommended, 33.3% of them found it ineffective, 28% 
participants stated that a repeat prescription of topical 
therapy was not easily accessible, 10.5% felt that topical 
therapy makes their skin worse, and 5.2% participants did 
not know which one to use and how frequently [Table 2]. 
There was a contradiction in patients’ views regarding the 
effectiveness of topical treatment. Around 8% participants 
found that Dermovate ointment was helpful, while 3.5% 
found it unhelpful. Similarly, 4.3% participants found that 
Dermol cream was helpful, while 2.6% found that the same 
cream was unhelpful.
Almost 29% of participants were on systemic therapy, 
including biologic therapy. Notably, 44.7% of participants 
had tried alternative therapies to improve their skin 
condition: 21% tried a special diet (e.g., gluten-free or dairy-
free), 16.6% tried homeopathy, 14.9% tried Chinese herbs, 
9.6% tried acupuncture, 6.1% tried yoga and meditation, 
5.2% tried cognitive behavior therapy (CBT), 4.3% tried 
mindfulness, 2.6% tried positive thinking, and one participant 
tried hypnotherapy [Table 2]. Although some patients found 
that alternative therapies did ease their distress or enable 
them to cope with their chronic disease, others thought that 
such therapy could make their skin rash worse.
Interview results
Twenty-two participants were interviewed. Female:male ratio 
was 10/12. Mean age 50.09 years. Three patients had eczema 
and the rest had psoriasis. Table 3 shows the demographics 
of the interviewees. Coding of their transcripts synthesized 5 
themes and 19 subthemes [Figure 3].
All the interviewees (n = 22) found that answering the 
questionnaire (study tool) was easy to fill out and helpful for 
the patients and for the physician:
Table 1: Participants characteristics and their DLQI 
score in the postal survey (n=114)
Total patients invited to 
participate in the study
505
Total patients agreed to 
participate
114
Female/male ratio for 
participants
58/56
Female/male ratio for non-
participants (n=391)
195/196
Mean age for participants 51.2 (range 18–88 years)
Mean age for non-participants 44.4 (range 18–88 years)
Psoriasis/Eczema ratio for 
participants
84/30
Psoriasis/Eczema ratio for 
non-participants
101/290
Participants used topical 
treatment
107
Participants used systemic 
and topical treatment
33
DLQI range for participants 0–26
Mean DLQI for male 
participants
8.45
Mean DLQI for female 
participants
8.1
Mean DLQI in eczema 
participants
10.7
Mean DLQI in psoriasis 
participants
8.29
DLQI: Dermatology life quality index
Figure 2: Participants’ needs
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“I think it would give the dermatologist a better understanding 
of how it affects us personally.”
“Everything you need you can put it in, so doctors can read it 
and aware about our needs.
“I can write what I want in the empty spaces (of the 
questionnaire).”
“Cumulative clinical knowledge help others and help to 
improve service quality.”
Table 2: The feedback of 114 participants in the postal survey
Participants’ view on topical 
therapy
n %
Participant found topical therapy 
inconvenient
44 38.5
Participant found topical therapy 
ineffective
38 33.3
Participants found repeat 
prescription was difficult to access
32 28
Participants who felt that topical 
therapy made their skin rash worse
12 10.5
Participants who do not know which 
topical therapy to use
6 5.2
Other patients’ comments on 
topical therapy
Sticky, GP reluctant to prescribe hospital topical treatment recommended by the 
dermatologist, ointments/creams provide short improvement and work slowly
Helpful topical treatment for some 
participants
Hydromol oint*, Dermovate oint, Dovobet gel/oint, Elocon oint, Diprosalic oint, 
Enstilar foam, Dermol cream, 50/50 ointment, can’t remember
Unhelpful topical treatment for other 
participants
All creams, Dovobet gel, Dermovate oint, Dermol cream, Diprosalic oint, E45 
cream, aqueous cream
Side effects of topical therapy Redness and soreness of the skin, skin irritations, slow improvement, thin skin
Participants tried other therapies
Special diet 24 21
Homeopathy 19 16.6
Chinese herbs 17 14.9
Acupuncture 11 9.6
Yoga and meditation 7 6.1
Cognitive behavior therapy 6 5.2
Mindfulness 5 4.3
Positive thinking 3 2.6
Hypnotherapy 1 0.8
Other tried the following therapies Diet (Neem powder, turmeric, oat bath, Gluten-free diet, dairy-free diet), using 
non-bio powder, GYM, antidepressant 
Triggers of skin rash flare
Stress 72 63.1
Cold weather 52 45.6
Other triggers Central heating, too much sugar, detergent, not enough sun, menses
Coping with chronic skin disease
Yes 72 63.1
No 33 28.9
Inability to deal with stigma 19 16.6
Lack of family support 10 8.7
*Oint: Ointment
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Table 3: Qualitative study population’s backgrounds
Participant number Age Sex Civil status Disease
1 25 Female Single Eczema
2 40 Female Married Psoriasis
3 41 Female Single Eczema
4 46 Female Married Psoriasis
5 51 Female Married Psoriasis
6 52 Female Single Psoriasis
7 57 Female Married Psoriasis
8 60 Female Married Psoriasis
9 66 Female Single Psoriasis
10 67 Female Married Psoriasis
11 20 Male Single Psoriasis
12 29 Male Single Eczema
13 42 Male Single Psoriasis
14 47 Male Single Psoriasis
15 49 Male Single Psoriasis
16 51 Male Married Psoriasis
17 52 Male Married Psoriasis
18 52 Male Single Psoriasis
19 56 Male Single Psoriasis
20 57 Male Married Psoriasis
21 63 Male Married Psoriasis
22 76 Male Married Psoriasis
Figure 3: The themes and subthemes generated from interviewing 22 participants
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“It is quite emotionally draining having this condition. Asking 
questions like this (in the Questionnaire) it just gives better 
overview of the patient.”
Nineteen participants (86%) preferred using the online 
version of the study tool or PPS were:
“PPS Save time, it can be done at any place without any time 
pressure.”
“Definitely, portal system, it is little bit easier because 
everyone on their phone.”
“We are living in such a tech world, so it would be quicker to 
do it online.”
“If it is online portal then you can save it if you get distracted 
and then go back and complete it.”
“Portal system is convenient, happy to do it regularly.”
“I forget to bring my medication and don’t know which one is 
bad/good, portal will help me.”
“Portal is paperless; provide update treatment profile, all 
over the world, help patient to cancel appointment, refill 
prescription, give non-bias feedback and without pressure.”
Participants’ opinion on the barriers that could prevent them 
from using the study tool regularly at each consultation was 
mainly the time. However, they acknowledged that they can 
fill out the questionnaire any time in between their follow-up 
visits.
Participants’ comments on using alternative tools or methods 
to support their needs:
“Patient forum where you meet other people.”
“Support group and you can talk about your condition.”
“May be online video telemedicine.”
“Posters information on site saying about skin diseases”.
“Local workshop and giving leaflets in different languages 
for awareness on treatment.”
“Dermatology nurses can be a source of help to contact with 
them generally.”
Participants expressed their feelings, needs, and feedback:
“Doctor and nurse never really ask you how skin disease 
affects your home life.”
“It would be positive thing if the dermatologist asks more 
question on how we cope.”
“Stress management sessions on the NHS.”
“I am interested to see how much chronic skin diseases affect 
mental health and relationship.”
“Sometimes the treatment that has been given to me doesn’t 
fit in with my working routine” “Going to work and even 
sometimes driving can be a pain for me because my skin dry 
up.”
“I can’t cope with stress and it means committing suicide, 
because I don’t think I can cope.”
“Consultation limitation disable patient to express their 
suffering of daily life, coping level.”
“A bit frustrating is just getting a repeat prescription for a 
tiny tube of cream or ointment and doesn’t last long to finish 
in few days and it is time consuming to keep asking for repeat 
prescriptions.”
“It would be interesting to see professional ask a little more 
about diet.”
“Needs online information on what diet to avoid.”
“Access to appointment booking.”
“I really enjoy swimming but embarrassed by the skin rash, 
people have asked me if I’ve had animal bites stings. Wish to 
have more public information in places like swimming pools 
etc.”
DISCUSSION
This research used a new tool to assess and support the needs 
of patients with psoriasis and eczema. The tool disclosed 
heterogeneous information on patients’ views, unmet needs, 
and unaddressed comorbidities. The findings were congruent 
with those from previous studies which have found that the 
effective management of chronic skin diseases is mediated by 
personal and service limitations and that these can negatively 
impact on a patient’s outcome, productivity, emotional and 
psychological well-being.[8,9] Although the national institute 
for health and care excellence recommended assessing 
patient’s metabolic, cardiovascular, and psychological 
comorbidities as well as managing the patient’s skin rash 
and arthritis,[10] the finding of the postal survey identified that 
metabolic and cardiovascular comorbidities were not always 
documented in the patients’ notes. Stress was reported to be 
the major triggering factor by participants and reviewing 
patient’s hospital notes; no psychological assessment tool was 
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used except for patients using biological therapy. A similar 
failure was reported in previous UK studies; physicians often 
miss the opportunity to assess the comorbidities under the 
skin and tend to focus only on managing the visible rash.[8,9]
Apart from offering a platform for the patients to address 
their needs and comorbidities, the study tool motivated the 
participants and enabled them to be actively involved in 
contributing to the management of their chronic disease. They 
addressed their symptoms, management barriers, treatment 
preferences, and appraised the quality of care they received. 
Such information can determine patient’s management 
outcome and quality of care.[4] In addition, the study tool 
identified a poor relationship between some patients and 
their physicians. Patient/physician barriers can significantly 
influence the patient’s management and compliance with the 
treatment.[8,9] Participants also expressed personal and social 
challenges in living with the stigma of the disease. Lack of 
public health awareness of skin diseases can subject such 
patients to different types of abuses.[4]
The DLQI score in this study did not correlate with the severity 
of the disease or with the type of treatment received and did not 
map all aspects of a patient’s health, including comorbidities 
and psychosocial challenges [Table1]. In contrast, the study 
tool explored patients’ needs and comorbidities and enabled 
the patients to address their feedback.
The low response rate in postal surveys is common and has 
been reported in previous studies.[11,12] In addition, analyzing 
the results of a postal survey was time consuming and labor 
intensive. We proposed using the online version instead. 
The majority of the participants welcomed using PPS as a 
convenient tool to support their care at different levels. Three 
participants, however, preferred using a paper questionnaire. 
Choices of paper or online questionnaire can be offered to 
diverse population. Further, PPS can be modified to an 
App accessed through a mobile phone and linked with 
other supportive services; patient information sheet, patient 
online forum, access to test results, appointment scheduling, 
medication refill, link with local mental health, CBT services, 
and with supportive dermatology charities.[7]
Furthermore, PPS can be designed to act as a prospective study 
providing a coding system and unobservable longitudinal 
data on the natural history and trends of chronic skin diseases 
as well as regularly screening patients with such diseases 
for comorbidities at an early stage. The coding and the data 
generated by the PPS can assist health care organizations in 
policymaking and resource allocation.[7]
CONCLUSIONS
Using the study tool was welcomed by all the participants 
and the majority of them preferred PPS. The tool motivated 
patients to be actively involved in decision making and self-
managing their chronic disease. It can also provide coding 
and longitudinal clinical data that may influence their 
management plan and quality of care. The tool provided a 
rich ground for designing a PPS. Future studies can evaluate 
the feasibility of developing PPS in different health care 
settings.
Limitations
The research did not include the service provider to assess 
their views, resources, and service limitations and to identify 
the feasibility and logistics of implementing the study tool 
within the limited consultation time. The study did not 
compare the response rate and the effectiveness of using the 
study tool with using alternative assessment tools. It also did 
not include children, patients with language barriers, learning 
or cognitive disabilities, and patients with no internet access. 
Such patients may have difficulty in understanding or using 
the study tool.
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